Progress in Radiopharmacy: Developments in Nuclear Medicine, cartea 10
Editat de P.H. Cox, Steven J. Mather, C.B. Sampson, C.R. Lazarusen Limba Engleză Hardback – 31 oct 1986
Toate formatele și edițiile | Preț | Express |
---|---|---|
Paperback (1) | 2060.93 lei 6-8 săpt. | |
SPRINGER NETHERLANDS – 3 noi 2011 | 2060.93 lei 6-8 săpt. | |
Hardback (1) | 3109.61 lei 6-8 săpt. | |
SPRINGER NETHERLANDS – 31 oct 1986 | 3109.61 lei 6-8 săpt. |
Din seria Developments in Nuclear Medicine
- 5% Preț: 346.14 lei
- 5% Preț: 1068.51 lei
- 5% Preț: 365.70 lei
- 5% Preț: 2057.20 lei
- 5% Preț: 363.05 lei
- 5% Preț: 1378.27 lei
- 5% Preț: 1372.76 lei
- 5% Preț: 634.46 lei
- 5% Preț: 359.13 lei
- 5% Preț: 697.37 lei
- 5% Preț: 690.25 lei
- 5% Preț: 357.18 lei
- 5% Preț: 690.95 lei
- 5% Preț: 2069.62 lei
- 5% Preț: 1373.65 lei
- 5% Preț: 694.88 lei
- 5% Preț: 1065.86 lei
- 5% Preț: 695.07 lei
- 5% Preț: 1073.68 lei
- 5% Preț: 357.88 lei
- 5% Preț: 687.95 lei
- 5% Preț: 1063.39 lei
- 5% Preț: 353.12 lei
- 5% Preț: 1066.60 lei
- 5% Preț: 1066.75 lei
- 5% Preț: 1068.51 lei
- 5% Preț: 1064.64 lei
- 5% Preț: 701.65 lei
- 5% Preț: 363.37 lei
- 5% Preț: 351.66 lei
- 5% Preț: 365.70 lei
- 15% Preț: 571.17 lei
- 5% Preț: 369.26 lei
- 5% Preț: 364.65 lei
- 5% Preț: 358.59 lei
Preț: 3109.61 lei
Preț vechi: 3273.27 lei
-5% Nou
Puncte Express: 4664
Preț estimativ în valută:
595.14€ • 627.84$ • 495.96£
595.14€ • 627.84$ • 495.96£
Carte tipărită la comandă
Livrare economică 03-17 ianuarie 25
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780898388237
ISBN-10: 0898388236
Pagini: 616
Ilustrații: XII, 616 p.
Dimensiuni: 155 x 235 x 35 mm
Greutate: 1.05 kg
Ediția:1986
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Nuclear Medicine
Locul publicării:Dordrecht, Netherlands
ISBN-10: 0898388236
Pagini: 616
Ilustrații: XII, 616 p.
Dimensiuni: 155 x 235 x 35 mm
Greutate: 1.05 kg
Ediția:1986
Editura: SPRINGER NETHERLANDS
Colecția Springer
Seria Developments in Nuclear Medicine
Locul publicării:Dordrecht, Netherlands
Public țintă
ResearchCuprins
I. Generator Systems for Ultra-Short-Lived Radionuclides.- Generators for ultra-short-lived radionuclides. Their potential and limitations.- The current status of the Os-191?Ir-191m generator.- Pharmaceutical aspects of Krypton-81m generators.- The Yttrium-87/Strontium-87m generator. A new approach to its preparation.- II. Positron Emitting Radiopharmaceuticals.- Positrons from generators.- Production of positron emitting radionuclides using cyclotrons.- III. Radiochemistry.- Cu(I) supported isotopic exchange of arylbound iodide, new future for fast high yield labelling.- Iodine labelled 5-iodo-2-thiouracil as a melanoma seeking agent: a potential drug for diagnosis and treatment.- The synthesis and biodistribution of a radioiodinated GM1 ganglioside derivative.- Advances in radiochemistry of Tc-99m.- New aspects of complexation of technetium with DTPA ligand.- Indium chemistry in radiopharmaceutical development.- New radiohalogenation: an overview.- IV. Recent Developments in Radiopharmacy Practice.- Computers in radiopharmacy.- New developments in radiopharmacy. Dispensing techniques.- Radiopharmacy information and reporting systems. An overview.- Training and education of pharmacists for radiopharmacy.- Quality control of radiopharmaceuticals: Recent developments in analytical techniques.- A multicentre evaluation of techniques for determination of the radiochemical purity of Tc99m-DTPA.- Implications of new imaging techniques for radiopharmacy.- V. Biological Fate of Radiopharmaceuticals.- Biological fate of renal agents.- Tc99m bone seeking phosphate compounds: Studies on in vivo and in vitro behaviour.- Colloids for functional studies of the reticuloendothelial system. Quality control and biological behaviour.- In vivo behaviour of radiopharmaceuticals formyocardial imaging and metabolic studies.- Incorporation dosimetry of I-131-meta-iodobenzylguanidine (I-131-MIBG).- VI. Radionuclides in Drug Formulation Studies.- Radionuclides in drug formulation studies.- Syringe extractables: Effects on radiopharmaceuticals.- Radiolabelled antibodies as radiopharmaceuticals.- The radiolabelling of monoclonal antibodies with In-111 and their application in vivo for detection of thyroid metastases.- Production, quality control and clinical application of In-111-labelled anti-tumour monoclonal antibody.- Characterization of blood-borne radiolabel and detection of anti-mouse IgC antibodies in cancer patients receiving radiolabelled monoclonal antibody for diagnostic immunoscintigraphy.- Protein based radiopharmaceuticals: Applicability of polyacryl-amide gel electrophoresis in the quality control of labelled protein preparation.- VII. Radiopharmaceutical Aerosols.- Inhaled aerosols: Deposition and clearance.- Radioaerosols: Production and characteristics.- Lung perfusion then ventilation using a Tc-99m aerosol: Experiences with a commercial system.- Author index.